Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.41 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31184689 | 0.93 | CNR1 (0.40) | CNR1HTTGPR35GPR55CHRM2 | |
| SCHEMBL31185019 | 0.85 | CNR1 (0.43) | CNR1HTTGPR35GPR55CHRM2 | |
| SCHEMBL31355611 | 0.83 | CNR1 (0.45) | CNR1HTTGPR35GPR55CHRM2 | |
| SCHEMBL3070533 | 0.82 | GPR55 (0.56) | CNR1HTTGPR35GPR55CHRM2 | |
| SCHEMBL29385169 | 0.82 | GPR55 (0.56) | CNR1HTTGPR35GPR55CHRM2 | |
| SCHEMBL31355591 | 0.82 | POLB (0.39) | ERN1KAT6A | |
| SCHEMBL3092453 | 0.81 | CNR1 (0.50) | CNR1HTTGPR35GPR55CHRM2 | |
| SCHEMBL31184919 | 0.81 | CNR1 (0.43) | CNR1HTTGPR35GPR55CHRM2 | |
| SCHEMBL31184961 | 0.81 | CNR1 (0.43) | CNR1HTTGPR35GPR55CHRM2 | |
| SCHEMBL3192059 | 0.79 | CNR1 (0.52) | CNR1HTTGPR35GPR55CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119330941-A | Antitumor compounds as UPR agonists and uses thereof | 南京圣和药业股份有限公司 | 2025-01-21 | — | — | CN | disclosed |
| CN-118812517-A | Antitumor compounds as UPR agonists and uses thereof | 南京圣和药业股份有限公司 | 2024-10-22 | — | — | CN | disclosed |